In the upcoming Jharkhand Assembly elections, the richest candidate, Aquil Akhtar, boasts a staggering ₹400 crore in assets, ...

Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its ...

Mavorixafor was generally well tolerated as a monotherapy and in combination with G-CSF, with no drug-related serious adverse ...

AP LAWCET counselling 2024 registration for phase 2 begins today. Eligible and interested candidates can register on the ...

The Andhra Pradesh State Council of Higher Education (APSCHE) has officially commenced the second phase registration process ...

X4 Pharmaceuticals ( (XFOR) ) has shared an announcement. X4 Pharmaceuticals has announced promising results from its Phase 2 trial of ...

In the EMPOWER trials, emraclidine was well-tolerated with a safety profile comparable to that observed in the Phase 1b trial. The most commonly reported adverse events in EMPOWER-1 and EMPOWER-2 ...

The next phase of the Downtown River Greenway is almost finished and the Sioux Falls Parks and Recreation is hosting a ribbon ...

Stay informed with our live blog covering India’s latest in politics, economy, crime, and general news. Get real-time updates on political developments, financial trends, crime reports, and important ...

Phase 2 of the Jharkhand Assembly elections 2024, slated to take place on November 20, will see dozens of 'crorepatis' ...